speb/financial-data huggingface dataset:
WRN.TO income_statement (annual, 2022-12-31) — Diluted EPS: -0.03
WRN.TO income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: -4994178.00
WRN.TO income_statement (annual, 2022-12-31) — EBIT: -5632367.00
WRN.TO income_statement (annual, 2022-12-31) — EBITDA: -5464473.00
WRN.TO cash_flow (annual, 2022-12-31) — End Cash Position: 1341267.00
WRN.TO cash_flow (annual, 2022-12-31) — Financing Cash Flow: -75897.00
WRN.TO cash_flow (annual, 2022-12-31) — Free Cash Flow: -24271046.00
WRN.TO cash_flow (annual, 2022-12-31) — Gain Loss On Investment Securities: 694320.00
WRN.TO income_statement (annual, 2022-12-31) — Gain On Sale Of Security: -705848.00
WRN.TO income_statement (annual, 2022-12-31) — General And Administrative Expense: 5158797.00
WRN.TO balance_sheet (annual, 2022-12-31) — Gross PPE: 89820929.00
WRN.TO income_statement (annual, 2022-12-31) — Gross Profit: -167894.00
WRN.TO income_statement (annual, 2022-12-31) — Interest Income: 584512.00
WRN.TO income_statement (annual, 2022-12-31) — Interest Income Non Operating: 584512.00
WRN.TO balance_sheet (annual, 2022-12-31) — Invested Capital: 109742218.00
WRN.TO cash_flow (annual, 2022-12-31) — Investing Cash Flow: -25926692.00
WRN.TO cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 0.00
WRN.TO balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 172308.00
WRN.TO balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 172308.00
WRN.TO cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -209062.00
WRN.TO cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 0.00
WRN.TO income_statement (annual, 2022-12-31) — Net Income: -4994178.00
WRN.TO income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -4994178.00
WRN.TO income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -4994178.00
WRN.TO income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -4994178.00
WRN.TO income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -4994178.00
WRN.TO cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: -4994178.00
WRN.TO income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -4994178.00
WRN.TO income_statement (annual, 2022-12-31) — Net Interest Income: 584512.00
WRN.TO cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: -5000000.00
WRN.TO cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: -209062.00
WRN.TO cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: -209062.00
WRN.TO income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: 584512.00
WRN.TO balance_sheet (annual, 2022-12-31) — Net PPE: 89820929.00
WRN.TO cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -279540.00
WRN.TO balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 109742218.00
WRN.TO income_statement (annual, 2022-12-31) — Normalized EBITDA: -4758625.00
WRN.TO income_statement (annual, 2022-12-31) — Normalized Income: -4288330.00
WRN.TO cash_flow (annual, 2022-12-31) — Operating Cash Flow: -3344354.00
WRN.TO cash_flow (annual, 2022-12-31) — Operating Gains Losses: 694320.00
WRN.TO income_statement (annual, 2022-12-31) — Operating Income: -5632367.00
WRN.TO income_statement (annual, 2022-12-31) — Operating Revenue: 0.00
WRN.TO balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 151597489.00
WRN.TO balance_sheet (annual, 2022-12-31) — Other Current Assets: 1441814.00
WRN.TO income_statement (annual, 2022-12-31) — Other Gand A: 1825470.00
WRN.TO income_statement (annual, 2022-12-31) — Other Income Expense: 53677.00
WRN.TO cash_flow (annual, 2022-12-31) — Other Non Cash Items: -721829.00
WRN.TO income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: 759525.00
WRN.TO income_statement (annual, 2022-12-31) — Other Operating Expenses: 305676.00
WRN.TO balance_sheet (annual, 2022-12-31) — Other Properties: 89820929.00
WRN.TO balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 21778535.00
WRN.TO balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 4222346.00
WRN.TO income_statement (annual, 2022-12-31) — Pretax Income: -4994178.00
WRN.TO cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 133165.00
WRN.TO cash_flow (annual, 2022-12-31) — Purchase Of Investment: -5000000.00
WRN.TO cash_flow (annual, 2022-12-31) — Purchase Of PPE: -279540.00
WRN.TO income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 167894.00
WRN.TO income_statement (annual, 2022-12-31) — Reconciled Depreciation: 167894.00
WRN.TO cash_flow (annual, 2022-12-31) — Repayment Of Debt: -209062.00
WRN.TO balance_sheet (annual, 2022-12-31) — Retained Earnings: -111591438.00
WRN.TO income_statement (annual, 2022-12-31) — Salaries And Wages: 3333327.00
WRN.TO cash_flow (annual, 2022-12-31) — Sale Of Investment: 0.00
WRN.TO income_statement (annual, 2022-12-31) — Selling General And Administration: 5158797.00
WRN.TO balance_sheet (annual, 2022-12-31) — Share Issued: 151597489.00
WRN.TO cash_flow (annual, 2022-12-31) — Stock Based Compensation: 1547703.00
WRN.TO balance_sheet (annual, 2022-12-31) — Stockholders Equity: 109742218.00
WRN.TO balance_sheet (annual, 2022-12-31) — Tangible Book Value: 109742218.00
WRN.TO income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
WRN.TO income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.00
WRN.TO balance_sheet (annual, 2022-12-31) — Total Assets: 114382545.00
WRN.TO balance_sheet (annual, 2022-12-31) — Total Capitalization: 109742218.00
WRN.TO balance_sheet (annual, 2022-12-31) — Total Debt: 417981.00
WRN.TO balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 109742218.00
WRN.TO income_statement (annual, 2022-12-31) — Total Expenses: 5632367.00
WRN.TO balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 4640327.00
WRN.TO balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 89820929.00
WRN.TO balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 172308.00
WRN.TO income_statement (annual, 2022-12-31) — Total Unusual Items: -705848.00
WRN.TO income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: -705848.00
WRN.TO cash_flow (annual, 2022-12-31) — Unrealized Gain Loss On Investment Securities: 694320.00
WRN.TO balance_sheet (annual, 2022-12-31) — Working Capital: 20093597.00
WRN.TO income_statement (annual, 2023-12-31) — +Operating Expense: 4928338.00
WRN.TO income_statement (annual, 2023-12-31) — +Total Revenue: 0.00
WRN.TO balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 38084656.00
WRN.TO income_statement (annual, 2023-12-31) — Basic Average Shares: 159763750.00
WRN.TO income_statement (annual, 2023-12-31) — Basic EPS: -0.02
WRN.TO cash_flow (annual, 2023-12-31) — Beginning Cash Position: 1341267.00
WRN.TO cash_flow (annual, 2023-12-31) — Capital Expenditure: -19900208.00
WRN.TO cash_flow (annual, 2023-12-31) — Capital Expenditure Reported: -19900208.00
WRN.TO balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 197813.00
WRN.TO balance_sheet (annual, 2023-12-31) — Capital Stock: 216289331.00
WRN.TO balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 25971261.00
WRN.TO balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 32067045.00
WRN.TO balance_sheet (annual, 2023-12-31) — Cash Equivalents: 22220754.00
WRN.TO balance_sheet (annual, 2023-12-31) — Cash Financial: 3750507.00
WRN.TO cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: 31065699.00
WRN.TO cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -3900208.00
WRN.TO cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: -2535497.00
WRN.TO cash_flow (annual, 2023-12-31) — Change In Other Current Assets: -10342.00
WRN.TO cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: -185439.00
WRN.TO cash_flow (annual, 2023-12-31) — Change In Receivables: 303551.00
WRN.TO cash_flow (annual, 2023-12-31) — Change In Working Capital: 107770.00
WRN.TO cash_flow (annual, 2023-12-31) — Changes In Cash: 24629994.00
WRN.TO balance_sheet (annual, 2023-12-31) — Common Stock: 216289331.00
WRN.TO balance_sheet (annual, 2023-12-31) — Common Stock Equity: 139444250.00
WRN.TO cash_flow (annual, 2023-12-31) — Common Stock Issuance: 29591624.00
WRN.TO income_statement (annual, 2023-12-31) — Cost Of Revenue: 206900.00
WRN.TO balance_sheet (annual, 2023-12-31) — Current Assets: 33349960.00
WRN.TO balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 185515.00
WRN.TO balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 185515.00
WRN.TO balance_sheet (annual, 2023-12-31) — Current Liabilities: 4461825.00
WRN.TO cash_flow (annual, 2023-12-31) — Depreciation: 206900.00
WRN.TO cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 206900.00
WRN.TO cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 206900.00
WRN.TO income_statement (annual, 2023-12-31) — Diluted Average Shares: 159763750.00
WRN.TO income_statement (annual, 2023-12-31) — Diluted EPS: -0.02
WRN.TO income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -3338299.00
WRN.TO income_statement (annual, 2023-12-31) — EBIT: -5135238.00
WRN.TO income_statement (annual, 2023-12-31) — EBITDA: -4928338.00
WRN.TO cash_flow (annual, 2023-12-31) — End Cash Position: 25971261.00
WRN.TO cash_flow (annual, 2023-12-31) — Financing Cash Flow: 31065699.00
WRN.TO cash_flow (annual, 2023-12-31) — Free Cash Flow: -22435705.00
WRN.TO cash_flow (annual, 2023-12-31) — Gain Loss On Investment Securities: -620800.00
WRN.TO income_statement (annual, 2023-12-31) — Gain On Sale Of Security: 619989.00
WRN.TO income_statement (annual, 2023-12-31) — General And Administrative Expense: 4637025.00
WRN.TO balance_sheet (annual, 2023-12-31) — Gross PPE: 110568413.00
WRN.TO income_statement (annual, 2023-12-31) — Gross Profit: -206900.00
WRN.TO income_statement (annual, 2023-12-31) — Interest Income: 1176950.00
WRN.TO income_statement (annual, 2023-12-31) — Interest Income Non Operating: 1176950.00
WRN.TO balance_sheet (annual, 2023-12-31) — Invested Capital: 139444250.00
WRN.TO cash_flow (annual, 2023-12-31) — Investing Cash Flow: -3900208.00
WRN.TO cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 29591624.00
WRN.TO balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 12298.00
WRN.TO balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 12298.00
WRN.TO cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -245672.00
WRN.TO cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 29591624.00
WRN.TO income_statement (annual, 2023-12-31) — Net Income: -3338299.00
WRN.TO income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -3338299.00
WRN.TO income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -3338299.00
WRN.TO income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -3338299.00
WRN.TO income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -3338299.00
WRN.TO cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -3338299.00
WRN.TO income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -3338299.00
WRN.TO income_statement (annual, 2023-12-31) — Net Interest Income: 1176950.00
WRN.TO cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: 16000000.00
WRN.TO cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: -245672.00
WRN.TO cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: -245672.00
WRN.TO income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: 1176950.00
WRN.TO cash_flow (annual, 2023-12-31) — Net Other Financing Charges: -305253.00
WRN.TO balance_sheet (annual, 2023-12-31) — Net PPE: 110568413.00
WRN.TO cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: 0.00
WRN.TO balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 139444250.00
WRN.TO income_statement (annual, 2023-12-31) — Normalized EBITDA: -5548327.00
WRN.TO income_statement (annual, 2023-12-31) — Normalized Income: -3958288.00
WRN.TO cash_flow (annual, 2023-12-31) — Operating Cash Flow: -2535497.00
WRN.TO cash_flow (annual, 2023-12-31) — Operating Gains Losses: -620800.00
WRN.TO income_statement (annual, 2023-12-31) — Operating Income: -5135238.00
WRN.TO income_statement (annual, 2023-12-31) — Operating Revenue: 0.00
WRN.TO balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 166091245.00
WRN.TO balance_sheet (annual, 2023-12-31) — Other Current Assets: 1282915.00
WRN.TO income_statement (annual, 2023-12-31) — Other Gand A: 1662777.00
WRN.TO income_statement (annual, 2023-12-31) — Other Income Expense: 619989.00
WRN.TO cash_flow (annual, 2023-12-31) — Other Non Cash Items: 25504.00
WRN.TO income_statement (annual, 2023-12-31) — Other Operating Expenses: 291313.00
WRN.TO balance_sheet (annual, 2023-12-31) — Other Properties: 110568413.00
WRN.TO balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 6095784.00
WRN.TO balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 4276310.00
WRN.TO income_statement (annual, 2023-12-31) — Pretax Income: -3338299.00
WRN.TO cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 2025000.00
WRN.TO cash_flow (annual, 2023-12-31) — Purchase Of Investment: -5000000.00
WRN.TO cash_flow (annual, 2023-12-31) — Purchase Of PPE: 0.00
WRN.TO income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 206900.00
WRN.TO income_statement (annual, 2023-12-31) — Reconciled Depreciation: 206900.00
WRN.TO cash_flow (annual, 2023-12-31) — Repayment Of Debt: -245672.00
WRN.TO balance_sheet (annual, 2023-12-31) — Retained Earnings: -114929737.00
WRN.TO income_statement (annual, 2023-12-31) — Salaries And Wages: 2974248.00
WRN.TO cash_flow (annual, 2023-12-31) — Sale Of Investment: 16000000.00
WRN.TO income_statement (annual, 2023-12-31) — Selling General And Administration: 4637025.00
WRN.TO balance_sheet (annual, 2023-12-31) — Share Issued: 166091245.00
WRN.TO cash_flow (annual, 2023-12-31) — Stock Based Compensation: 1083428.00
WRN.TO balance_sheet (annual, 2023-12-31) — Stockholders Equity: 139444250.00
WRN.TO balance_sheet (annual, 2023-12-31) — Tangible Book Value: 139444250.00
WRN.TO income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
WRN.TO income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.00
WRN.TO balance_sheet (annual, 2023-12-31) — Total Assets: 143918373.00
WRN.TO balance_sheet (annual, 2023-12-31) — Total Capitalization: 139444250.00
WRN.TO balance_sheet (annual, 2023-12-31) — Total Debt: 197813.00
WRN.TO balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 139444250.00
WRN.TO income_statement (annual, 2023-12-31) — Total Expenses: 5135238.00
WRN.TO balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 4474123.00
WRN.TO balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 110568413.00
WRN.TO balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 12298.00
WRN.TO income_statement (annual, 2023-12-31) — Total Unusual Items: 619989.00
WRN.TO income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: 619989.00
WRN.TO balance_sheet (annual, 2023-12-31) — Working Capital: 28888135.00
WRN.TO income_statement (quarterly, 2024-09-30) — Basic Average Shares: 198219077.00
WRN.TO income_statement (quarterly, 2024-09-30) — Basic EPS: 0.00
WRN.TO cash_flow (quarterly, 2024-09-30) — Change In Account Payable: -78288.00
WRN.TO cash_flow (quarterly, 2024-09-30) — Change In Accrued Expense: -1117812.00
WRN.TO cash_flow (quarterly, 2024-09-30) — Change In Interest Payable: -1117812.00
WRN.TO cash_flow (quarterly, 2024-09-30) — Change In Other Current Assets: 533880.00
WRN.TO cash_flow (quarterly, 2024-09-30) — Change In Payable: -78288.00
WRN.TO cash_flow (quarterly, 2024-09-30) — Change In Payables And Accrued Expense: -1196100.00
WRN.TO income_statement (quarterly, 2024-09-30) — Diluted Average Shares: 198219077.00
WRN.TO income_statement (quarterly, 2024-09-30) — Diluted EPS: 0.00
WRN.TO cash_flow (quarterly, 2024-09-30) — Net Other Financing Charges: 0.00
WRN.TO cash_flow (quarterly, 2024-09-30) — Net PPE Purchase And Sale: 0.00
WRN.TO cash_flow (quarterly, 2024-09-30) — Purchase Of Investment: 0.00
WRN.TO cash_flow (quarterly, 2024-09-30) — Purchase Of PPE: 0.00
WRN.TO cash_flow (quarterly, 2024-09-30) — Sale Of Investment: 0.00
WRN.TO income_statement (annual, 2024-12-31) — +Operating Expense: 9485731.00
WRN.TO income_statement (annual, 2024-12-31) — +Total Revenue: 0.00
WRN.TO balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 38916835.00
WRN.TO income_statement (annual, 2024-12-31) — Basic Average Shares: 187910004.00
WRN.TO income_statement (annual, 2024-12-31) — Basic EPS: -0.04
WRN.TO cash_flow (annual, 2024-12-31) — Beginning Cash Position: 25971261.00
WRN.TO cash_flow (annual, 2024-12-31) — Capital Expenditure: -13824762.00
WRN.TO cash_flow (annual, 2024-12-31) — Capital Expenditure Reported: -13824762.00
WRN.TO balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 60639.00
WRN.TO balance_sheet (annual, 2024-12-31) — Capital Stock: 272544984.00
WRN.TO balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 14202317.00
WRN.TO balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 69052191.00
WRN.TO balance_sheet (annual, 2024-12-31) — Cash Equivalents: 7462085.00
WRN.TO balance_sheet (annual, 2024-12-31) — Cash Financial: 6740232.00
WRN.TO cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: 54285176.00
WRN.TO cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -61324762.00
WRN.TO cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: -4729358.00
WRN.TO cash_flow (annual, 2024-12-31) — Change In Other Current Assets: -33351.00
WRN.TO cash_flow (quarterly, 2024-12-31) — Change In Other Current Assets: -374026.00
WRN.TO cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: 860816.00
WRN.TO cash_flow (quarterly, 2024-12-31) — Change In Payables And Accrued Expense: 1495593.00
WRN.TO cash_flow (annual, 2024-12-31) — Change In Receivables: -1205770.00
WRN.TO cash_flow (annual, 2024-12-31) — Change In Working Capital: -378305.00
WRN.TO cash_flow (annual, 2024-12-31) — Changes In Cash: -11768944.00
WRN.TO balance_sheet (annual, 2024-12-31) — Common Stock: 272544984.00
WRN.TO balance_sheet (annual, 2024-12-31) — Common Stock Equity: 189610252.00
WRN.TO cash_flow (annual, 2024-12-31) — Common Stock Issuance: 54282153.00
WRN.TO income_statement (annual, 2024-12-31) — Cost Of Revenue: 157059.00
WRN.TO balance_sheet (annual, 2024-12-31) — Current Assets: 70007044.00
WRN.TO balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 33408.00
WRN.TO balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 33408.00
WRN.TO balance_sheet (annual, 2024-12-31) — Current Liabilities: 3155903.00
WRN.TO cash_flow (annual, 2024-12-31) — Depreciation: 157659.00
WRN.TO cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 157659.00
WRN.TO cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 157659.00
WRN.TO income_statement (annual, 2024-12-31) — Diluted Average Shares: 187910004.00
WRN.TO income_statement (annual, 2024-12-31) — Diluted EPS: -0.04
WRN.TO income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -6921830.00
WRN.TO income_statement (annual, 2024-12-31) — EBIT: -9642790.00
WRN.TO income_statement (annual, 2024-12-31) — EBITDA: -9485131.00
WRN.TO cash_flow (annual, 2024-12-31) — End Cash Position: 14202317.00
WRN.TO cash_flow (annual, 2024-12-31) — Financing Cash Flow: 54285176.00
WRN.TO cash_flow (annual, 2024-12-31) — Free Cash Flow: -18554120.00
WRN.TO cash_flow (annual, 2024-12-31) — Gain Loss On Investment Securities: -48320.00
WRN.TO income_statement (annual, 2024-12-31) — Gain On Sale Of Security: 44452.00
WRN.TO income_statement (annual, 2024-12-31) — General And Administrative Expense: 9139385.00
WRN.TO balance_sheet (annual, 2024-12-31) — Gross PPE: 122786342.00
WRN.TO income_statement (annual, 2024-12-31) — Gross Profit: -157059.00
WRN.TO income_statement (annual, 2024-12-31) — Interest Income: 2676508.00
WRN.TO income_statement (annual, 2024-12-31) — Interest Income Non Operating: 2676508.00
WRN.TO balance_sheet (annual, 2024-12-31) — Invested Capital: 189610252.00
WRN.TO cash_flow (annual, 2024-12-31) — Investing Cash Flow: -61324762.00
WRN.TO cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 54282153.00
WRN.TO balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 27231.00
WRN.TO balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 27231.00
WRN.TO cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -188174.00
WRN.TO cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 54282153.00
WRN.TO income_statement (annual, 2024-12-31) — Net Income: -6921830.00
WRN.TO income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -6921830.00
WRN.TO income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -6921830.00
WRN.TO income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -6921830.00
WRN.TO income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -6921830.00
WRN.TO cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -6921830.00
WRN.TO income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -6921830.00
WRN.TO income_statement (annual, 2024-12-31) — Net Interest Income: 2676508.00
WRN.TO cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: -47500000.00
WRN.TO cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: -188174.00
WRN.TO cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: -188174.00
WRN.TO income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: 2676508.00
WRN.TO cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -3273803.00
WRN.TO cash_flow (quarterly, 2024-12-31) — Net Other Financing Charges: -30337.00
WRN.TO balance_sheet (annual, 2024-12-31) — Net PPE: 122786342.00
WRN.TO cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: 0.00
WRN.TO balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 189610252.00
WRN.TO income_statement (annual, 2024-12-31) — Normalized EBITDA: -9529583.00
WRN.TO income_statement (annual, 2024-12-31) — Normalized Income: -6966282.00
WRN.TO cash_flow (annual, 2024-12-31) — Operating Cash Flow: -4729358.00
WRN.TO cash_flow (annual, 2024-12-31) — Operating Gains Losses: -48320.00
WRN.TO income_statement (annual, 2024-12-31) — Operating Income: -9642790.00
WRN.TO income_statement (annual, 2024-12-31) — Operating Revenue: 0.00
WRN.TO balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 198391318.00
WRN.TO balance_sheet (annual, 2024-12-31) — Other Current Assets: 954853.00
WRN.TO income_statement (annual, 2024-12-31) — Other Gand A: 2262641.00
WRN.TO income_statement (annual, 2024-12-31) — Other Income Expense: 44452.00
WRN.TO cash_flow (annual, 2024-12-31) — Other Non Cash Items: 8298.00
WRN.TO income_statement (annual, 2024-12-31) — Other Operating Expenses: 346346.00
WRN.TO balance_sheet (annual, 2024-12-31) — Other Properties: 122786342.00
WRN.TO balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 54849874.00
WRN.TO balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 3122495.00
WRN.TO income_statement (annual, 2024-12-31) — Pretax Income: -6921830.00
WRN.TO cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 3465000.00
WRN.TO cash_flow (annual, 2024-12-31) — Purchase Of Investment: -47500000.00
WRN.TO cash_flow (quarterly, 2024-12-31) — Purchase Of Investment: 3697377.00
WRN.TO cash_flow (annual, 2024-12-31) — Purchase Of PPE: 0.00
WRN.TO income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 157059.00
WRN.TO income_statement (annual, 2024-12-31) — Reconciled Depreciation: 157659.00
WRN.TO cash_flow (annual, 2024-12-31) — Repayment Of Debt: -188174.00
WRN.TO balance_sheet (annual, 2024-12-31) — Retained Earnings: -121851567.00
WRN.TO income_statement (annual, 2024-12-31) — Salaries And Wages: 6876744.00
WRN.TO cash_flow (annual, 2024-12-31) — Sale Of Investment: 0.00
WRN.TO income_statement (annual, 2024-12-31) — Selling General And Administration: 9139385.00
WRN.TO balance_sheet (annual, 2024-12-31) — Share Issued: 198391318.00
WRN.TO cash_flow (annual, 2024-12-31) — Stock Based Compensation: 2453140.00
WRN.TO balance_sheet (annual, 2024-12-31) — Stockholders Equity: 189610252.00
WRN.TO balance_sheet (annual, 2024-12-31) — Tangible Book Value: 189610252.00
WRN.TO income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
WRN.TO income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.00
WRN.TO balance_sheet (annual, 2024-12-31) — Total Assets: 192793386.00
WRN.TO balance_sheet (annual, 2024-12-31) — Total Capitalization: 189610252.00
WRN.TO balance_sheet (annual, 2024-12-31) — Total Debt: 60639.00
WRN.TO balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 189610252.00
WRN.TO income_statement (annual, 2024-12-31) — Total Expenses: 9642790.00
WRN.TO balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 3183134.00
WRN.TO balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 122786342.00
WRN.TO balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 27231.00
WRN.TO income_statement (annual, 2024-12-31) — Total Unusual Items: 44452.00
WRN.TO income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: 44452.00
WRN.TO balance_sheet (annual, 2024-12-31) — Working Capital: 66851141.00
WRN.TO income_statement (quarterly, 2025-03-31) — +Operating Expense: 2076962.00
WRN.TO income_statement (quarterly, 2025-03-31) — +Total Revenue: 0.00
WRN.TO balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 39199490.00
WRN.TO income_statement (quarterly, 2025-03-31) — Basic Average Shares: 199089677.00
WRN.TO income_statement (quarterly, 2025-03-31) — Basic EPS: 0.00
WRN.TO cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 14202317.00
WRN.TO cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -4334741.00
WRN.TO cash_flow (quarterly, 2025-03-31) — Capital Expenditure Reported: -4334741.00
WRN.TO balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 42398.00
WRN.TO balance_sheet (quarterly, 2025-03-31) — Capital Stock: 274337363.00
WRN.TO balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 10145713.00
WRN.TO balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 64765462.00
WRN.TO balance_sheet (quarterly, 2025-03-31) — Cash Equivalents: 3762042.00
WRN.TO balance_sheet (quarterly, 2025-03-31) — Cash Financial: 6383671.00
WRN.TO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: 1255712.00
WRN.TO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -3090935.00
WRN.TO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -2221381.00
WRN.TO cash_flow (quarterly, 2025-03-31) — Change In Account Payable: -1288152.00
WRN.TO cash_flow (quarterly, 2025-03-31) — Change In Accrued Expense: -238681.00
WRN.TO cash_flow (quarterly, 2025-03-31) — Change In Interest Payable: -238681.00
WRN.TO cash_flow (quarterly, 2025-03-31) — Change In Other Current Assets: 58106.00
WRN.TO cash_flow (quarterly, 2025-03-31) — Change In Payable: -1288152.00
WRN.TO cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -1288152.00
WRN.TO cash_flow (quarterly, 2025-03-31) — Change In Receivables: -238681.00
WRN.TO cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -1468727.00
WRN.TO cash_flow (quarterly, 2025-03-31) — Changes In Cash: -4056604.00
WRN.TO balance_sheet (quarterly, 2025-03-31) — Common Stock: 274337363.00
WRN.TO balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 191048220.00
WRN.TO cash_flow (quarterly, 2025-03-31) — Common Stock Issuance: 0.00
WRN.TO income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 16561.00
WRN.TO balance_sheet (quarterly, 2025-03-31) — Current Assets: 65827653.00
WRN.TO balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 18663.00
WRN.TO balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 18663.00
WRN.TO balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 2926843.00
WRN.TO cash_flow (quarterly, 2025-03-31) — Depreciation: 16561.00
WRN.TO cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 16561.00
WRN.TO cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 16561.00
WRN.TO income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 199089677.00
WRN.TO income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.00
WRN.TO income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -637066.00
WRN.TO income_statement (quarterly, 2025-03-31) — EBIT: -2093523.00
WRN.TO income_statement (quarterly, 2025-03-31) — EBITDA: -2076962.00
WRN.TO cash_flow (quarterly, 2025-03-31) — End Cash Position: 10145713.00
WRN.TO cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 1255712.00
WRN.TO cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -6556122.00
WRN.TO cash_flow (quarterly, 2025-03-31) — Gain Loss On Investment Securities: -775000.00
WRN.TO income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: 790093.00
WRN.TO income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 1839664.00
WRN.TO balance_sheet (quarterly, 2025-03-31) — Gross PPE: 128171145.00
WRN.TO income_statement (quarterly, 2025-03-31) — Gross Profit: -16561.00
WRN.TO income_statement (quarterly, 2025-03-31) — Interest Income: 666364.00
WRN.TO income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 666364.00
WRN.TO balance_sheet (quarterly, 2025-03-31) — Invested Capital: 191048220.00
WRN.TO cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -3090935.00
WRN.TO cash_flow (quarterly, 2025-03-31) — Issuance Of Capital Stock: 0.00
WRN.TO balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 23735.00
WRN.TO balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 23735.00
WRN.TO cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -19288.00
WRN.TO cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: 0.00
WRN.TO income_statement (quarterly, 2025-03-31) — Net Income: -637066.00
WRN.TO income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -637066.00
WRN.TO income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -637066.00
WRN.TO income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -637066.00
WRN.TO income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -637066.00
WRN.TO cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -637066.00
WRN.TO income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -637066.00
WRN.TO income_statement (quarterly, 2025-03-31) — Net Interest Income: 666364.00
WRN.TO cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: 1243806.00
WRN.TO cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: -19288.00
WRN.TO cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: -19288.00
WRN.TO income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: 666364.00
WRN.TO balance_sheet (quarterly, 2025-03-31) — Net PPE: 128171145.00
WRN.TO balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 191048220.00
WRN.TO income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -2867055.00
WRN.TO income_statement (quarterly, 2025-03-31) — Normalized Income: -1427159.00
WRN.TO cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -2221381.00
WRN.TO cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: -775000.00
WRN.TO income_statement (quarterly, 2025-03-31) — Operating Income: -2093523.00
WRN.TO income_statement (quarterly, 2025-03-31) — Operating Revenue: 0.00
WRN.TO balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 200000258.00
WRN.TO balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 1062191.00
WRN.TO income_statement (quarterly, 2025-03-31) — Other Gand A: 461235.00
WRN.TO income_statement (quarterly, 2025-03-31) — Other Income Expense: 790093.00
WRN.TO cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 1047.00
WRN.TO income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 237298.00
WRN.TO balance_sheet (quarterly, 2025-03-31) — Other Properties: 128171145.00
WRN.TO balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 54619749.00
WRN.TO balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 2908180.00
WRN.TO income_statement (quarterly, 2025-03-31) — Pretax Income: -637066.00
WRN.TO cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 1275000.00
WRN.TO income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 16561.00
WRN.TO income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 16561.00
WRN.TO cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -19288.00
WRN.TO balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -122488633.00
WRN.TO income_statement (quarterly, 2025-03-31) — Salaries And Wages: 1378429.00
WRN.TO income_statement (quarterly, 2025-03-31) — Selling General And Administration: 1839664.00
WRN.TO balance_sheet (quarterly, 2025-03-31) — Share Issued: 200000258.00
WRN.TO cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 641804.00
WRN.TO balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 191048220.00
WRN.TO balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 191048220.00
WRN.TO income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
WRN.TO income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.00
WRN.TO balance_sheet (quarterly, 2025-03-31) — Total Assets: 193998798.00
WRN.TO balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 191048220.00
WRN.TO balance_sheet (quarterly, 2025-03-31) — Total Debt: 42398.00
WRN.TO balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 191048220.00
WRN.TO income_statement (quarterly, 2025-03-31) — Total Expenses: 2093523.00
WRN.TO balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 2950578.00
WRN.TO balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 128171145.00
WRN.TO balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 23735.00
WRN.TO income_statement (quarterly, 2025-03-31) — Total Unusual Items: 790093.00
WRN.TO income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 790093.00
WRN.TO cash_flow (quarterly, 2025-03-31) — Unrealized Gain Loss On Investment Securities: -775000.00
WRN.TO balance_sheet (quarterly, 2025-03-31) — Working Capital: 62900810.00
WRN.TO income_statement (quarterly, 2025-06-30) — +Operating Expense: 2043584.00
WRN.TO income_statement (quarterly, 2025-06-30) — +Total Revenue: 0.00
WRN.TO balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 39440933.00
WRN.TO income_statement (quarterly, 2025-06-30) — Basic Average Shares: 200143421.00
WRN.TO income_statement (quarterly, 2025-06-30) — Basic EPS: 0.00
WRN.TO cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 10145713.00
WRN.TO cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -4777337.00
WRN.TO cash_flow (quarterly, 2025-06-30) — Capital Expenditure Reported: -4727262.00
WRN.TO balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 247089.00
WRN.TO balance_sheet (quarterly, 2025-06-30) — Capital Stock: 275365655.00
WRN.TO balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 17798278.00
WRN.TO balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 60854404.00
WRN.TO balance_sheet (quarterly, 2025-06-30) — Cash Equivalents: 10799830.00
WRN.TO balance_sheet (quarterly, 2025-06-30) — Cash Financial: 6998448.00
WRN.TO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: 418162.00
WRN.TO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: 7695460.00
WRN.TO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: -461057.00
WRN.TO cash_flow (quarterly, 2025-06-30) — Change In Account Payable: 266304.00
WRN.TO cash_flow (quarterly, 2025-06-30) — Change In Accrued Expense: 0.00
WRN.TO cash_flow (quarterly, 2025-06-30) — Change In Interest Payable: 0.00
WRN.TO cash_flow (quarterly, 2025-06-30) — Change In Other Current Assets: 120383.00
WRN.TO cash_flow (quarterly, 2025-06-30) — Change In Payable: 266304.00
WRN.TO cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 27623.00
WRN.TO cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 386687.00
WRN.TO cash_flow (quarterly, 2025-06-30) — Changes In Cash: 7652565.00
WRN.TO balance_sheet (quarterly, 2025-06-30) — Common Stock: 275365655.00
WRN.TO balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 191689960.00
WRN.TO cash_flow (quarterly, 2025-06-30) — Common Stock Issuance: 0.00
WRN.TO income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 16821.00
WRN.TO balance_sheet (quarterly, 2025-06-30) — Current Assets: 61548838.00
WRN.TO balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 123434.00
WRN.TO balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 123434.00
WRN.TO balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 5341159.00
WRN.TO cash_flow (quarterly, 2025-06-30) — Depreciation: 16821.00
WRN.TO cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 16821.00
WRN.TO cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 16821.00
WRN.TO income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 200143421.00
WRN.TO income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.00
WRN.TO income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -627995.00
WRN.TO income_statement (quarterly, 2025-06-30) — EBIT: -2060405.00
WRN.TO income_statement (quarterly, 2025-06-30) — EBITDA: -2043584.00
WRN.TO cash_flow (quarterly, 2025-06-30) — End Cash Position: 17798278.00
WRN.TO cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 418162.00
WRN.TO cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -5238394.00
WRN.TO cash_flow (quarterly, 2025-06-30) — Gain Loss On Investment Securities: -909174.00
WRN.TO income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: 891052.00
WRN.TO income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 2002175.00
WRN.TO balance_sheet (quarterly, 2025-06-30) — Gross PPE: 135605936.00
WRN.TO income_statement (quarterly, 2025-06-30) — Gross Profit: -16821.00
WRN.TO income_statement (quarterly, 2025-06-30) — Interest Income: 541358.00
WRN.TO income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 541358.00
WRN.TO balance_sheet (quarterly, 2025-06-30) — Invested Capital: 191689960.00
WRN.TO cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: 7695460.00
WRN.TO cash_flow (quarterly, 2025-06-30) — Issuance Of Capital Stock: 0.00
WRN.TO balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 123655.00
WRN.TO balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 123655.00
WRN.TO cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -11338.00
WRN.TO cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: 0.00
WRN.TO income_statement (quarterly, 2025-06-30) — Net Income: -627995.00
WRN.TO income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -627995.00
WRN.TO income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -627995.00
WRN.TO income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -627995.00
WRN.TO income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -627995.00
WRN.TO cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -627995.00
WRN.TO income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -627995.00
WRN.TO income_statement (quarterly, 2025-06-30) — Net Interest Income: 541358.00
WRN.TO cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: 12472797.00
WRN.TO cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: -11338.00
WRN.TO cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: -11338.00
WRN.TO income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: 541358.00
WRN.TO balance_sheet (quarterly, 2025-06-30) — Net PPE: 135605936.00
WRN.TO balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 191689960.00
WRN.TO income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -2934636.00
WRN.TO income_statement (quarterly, 2025-06-30) — Normalized Income: -1519047.00
WRN.TO cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -461057.00
WRN.TO cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: -909174.00
WRN.TO income_statement (quarterly, 2025-06-30) — Operating Income: -2060405.00
WRN.TO income_statement (quarterly, 2025-06-30) — Operating Revenue: 0.00
WRN.TO balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 200554324.00
WRN.TO balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 694434.00
WRN.TO income_statement (quarterly, 2025-06-30) — Other Gand A: 573158.00
WRN.TO income_statement (quarterly, 2025-06-30) — Other Income Expense: 891052.00
WRN.TO cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: -75248.00
WRN.TO income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 41409.00
WRN.TO balance_sheet (quarterly, 2025-06-30) — Other Properties: 135605936.00
WRN.TO balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 43056126.00
WRN.TO balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 5217725.00
WRN.TO income_statement (quarterly, 2025-06-30) — Pretax Income: -627995.00
WRN.TO cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 429500.00
WRN.TO income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 16821.00
WRN.TO income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 16821.00
WRN.TO cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -11338.00
WRN.TO balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -123116628.00
WRN.TO income_statement (quarterly, 2025-06-30) — Salaries And Wages: 1429017.00
WRN.TO income_statement (quarterly, 2025-06-30) — Selling General And Administration: 2002175.00
WRN.TO balance_sheet (quarterly, 2025-06-30) — Share Issued: 200554324.00
WRN.TO cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 747852.00
WRN.TO balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 191689960.00
WRN.TO balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 191689960.00
WRN.TO income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
WRN.TO income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.00
WRN.TO balance_sheet (quarterly, 2025-06-30) — Total Assets: 197154774.00
WRN.TO balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 191689960.00
WRN.TO balance_sheet (quarterly, 2025-06-30) — Total Debt: 247089.00
WRN.TO balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 191689960.00
WRN.TO income_statement (quarterly, 2025-06-30) — Total Expenses: 2060405.00
WRN.TO balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 5464814.00
WRN.TO balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 135605936.00
WRN.TO balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 123655.00
WRN.TO income_statement (quarterly, 2025-06-30) — Total Unusual Items: 891052.00
WRN.TO income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 891052.00
WRN.TO balance_sheet (quarterly, 2025-06-30) — Working Capital: 56207679.00
WRN.TO income_statement (quarterly, 2025-09-30) — +Operating Expense: 1802939.00
WRN.TO income_statement (quarterly, 2025-09-30) — +Total Revenue: 0.00
WRN.TO balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 39005151.00
WRN.TO income_statement (quarterly, 2025-09-30) — Basic Average Shares: 201393862.00
WRN.TO income_statement (quarterly, 2025-09-30) — Basic EPS: 0.00
WRN.TO cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 17798278.00
WRN.TO cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -6058336.00
WRN.TO cash_flow (quarterly, 2025-09-30) — Capital Expenditure Reported: -6058336.00
WRN.TO balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 278844.00
WRN.TO balance_sheet (quarterly, 2025-09-30) — Capital Stock: 277814004.00
WRN.TO balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 10400485.00
WRN.TO balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 56109210.00
WRN.TO balance_sheet (quarterly, 2025-09-30) — Cash Equivalents: 3817490.00
WRN.TO balance_sheet (quarterly, 2025-09-30) — Cash Financial: 6582995.00
WRN.TO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 1395958.00
WRN.TO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -9015223.00
WRN.TO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 221472.00
WRN.TO cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 1135364.00
WRN.TO cash_flow (quarterly, 2025-09-30) — Changes In Cash: -7397793.00
WRN.TO balance_sheet (quarterly, 2025-09-30) — Common Stock: 277814004.00
WRN.TO balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 192812235.00
WRN.TO cash_flow (quarterly, 2025-09-30) — Common Stock Issuance: 0.00
WRN.TO income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 31333.00
WRN.TO balance_sheet (quarterly, 2025-09-30) — Current Assets: 56687586.00
WRN.TO balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 186452.00
WRN.TO balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 186452.00
WRN.TO balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 5382698.00
WRN.TO cash_flow (quarterly, 2025-09-30) — Depreciation: 31333.00
WRN.TO cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 31333.00
WRN.TO cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 31333.00
WRN.TO income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 201393862.00
WRN.TO income_statement (quarterly, 2025-09-30) — Diluted EPS: 0.00
WRN.TO income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -890292.00
WRN.TO income_statement (quarterly, 2025-09-30) — EBIT: -1834272.00
WRN.TO income_statement (quarterly, 2025-09-30) — EBITDA: -1802939.00
WRN.TO cash_flow (quarterly, 2025-09-30) — End Cash Position: 10400485.00
WRN.TO cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 1395958.00
WRN.TO cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -5836864.00
WRN.TO cash_flow (quarterly, 2025-09-30) — Gain Loss On Investment Securities: -534133.00
WRN.TO income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: 537356.00
WRN.TO income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 1777655.00
WRN.TO balance_sheet (quarterly, 2025-09-30) — Gross PPE: 141599739.00
WRN.TO income_statement (quarterly, 2025-09-30) — Gross Profit: -31333.00
WRN.TO income_statement (quarterly, 2025-09-30) — Interest Income: 406624.00
WRN.TO income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 406624.00
WRN.TO balance_sheet (quarterly, 2025-09-30) — Invested Capital: 192812235.00
WRN.TO cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -9015223.00